AbogenBio
Abogen Biosciences (Suzhou Abogen Biosciences, 苏州艾博生物科技有限公司) is an industry-leading clinical-stage biotech company founded in January 2019 and headquartered in Suzhou, China, dedicated to developing transformative medicines through messenger RNA (mRNA) innovation. The company has built full-scale in
AbogenBio is an API provider whose private shares are listed on 1 secondary market: Nasdaq Private Market.
Where It Trades
Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.
Work with this as data
Every listing here is available over the APIs.io API and to AI agents over MCP. Secondary Market is not yet its own endpoint on the v1 API. Reach it through catalog search and the tag graph, or the MCP server.